Q3 2023 13F Holders as of 9/30/2023
-
Type / Class
-
Equity / Common Stock, $0.01 par value per share
-
Shares outstanding
-
50.5M
-
Number of holders
-
603
-
Total 13F shares, excl. options
-
50.4M
-
Shares change
-
+770K
-
Total reported value, excl. options
-
$9.86B
-
Value change
-
+$147M
-
Put/Call ratio
-
1.51
-
Number of buys
-
293
-
Number of sells
-
-267
-
Price
-
$195.98
Significant Holders of CHARLES RIVER LABORATORIES INTERNATIONAL, INC. - Common Stock, $0.01 par value per share (CRL) as of Q3 2023
698 filings reported holding CRL - CHARLES RIVER LABORATORIES INTERNATIONAL, INC. - Common Stock, $0.01 par value per share as of Q3 2023.
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. - Common Stock, $0.01 par value per share (CRL) has 603 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 50.4M shares
of 50.5M outstanding shares and own 99.74% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (5.95M shares), BlackRock Inc. (5.12M shares), STATE STREET CORP (2.03M shares), KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC (1.75M shares), Clearbridge Investments, LLC (1.75M shares), PRICE T ROWE ASSOCIATES INC /MD/ (1.68M shares), Allspring Global Investments Holdings, LLC (1.2M shares), GEODE CAPITAL MANAGEMENT, LLC (1.12M shares), ARIEL INVESTMENTS, LLC (1.07M shares), and Invesco Ltd. (928K shares).
This table shows the top 603 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.